Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

PRESIDENT & CEO

SEE REMARKS

Black Diamond Therapeutics, Inc., a clinical-stage precision oncology medicine company, focuses on the discovery and development of therapies for patients with genetically defined cancers. The company's lead product candidate, BDTX-1535, a brain-penetrant, mutant selective, irreversible EGFR MasterKey inhibitor, designed to inhibit a family of oncogenic mutations, currently under Phase 1 clinical trial. It also develops BDTX-4933, a brain penetrant RAF MasterKey inhibitor, designed to be a brain penetrant and highly selective and potent inhibitor of oncogenic BRAF Class I, II, III and active RAF dimers, expected to initiate Phase 1 clinical trial. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Black Diamond Therapeutics, Inc., a clinical-stage precision oncology medicine company, focuses on the discovery and development of therap...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-15	Premium	acquired	Premium	Premium	Premium	-
2024-03-15	Premium	acquired	Premium	Premium	Premium	-
2023-12-15	Premium	acquired	Premium	Premium	Premium	-
2023-12-15	Premium	acquired	Premium	Premium	Premium	-
2023-10-17	Premium	bought	Premium	Premium	Premium	-
2023-09-15	Premium	acquired	Premium	Premium	Premium	PRESIDENT & CEO
2023-09-15	Premium	acquired	Premium	Premium	Premium	-
2023-09-15	Premium	acquired	Premium	Premium	Premium	-
2023-07-05	Premium	bought	Premium	Premium	Premium	-
2023-07-05	Premium	bought	Premium	Premium	Premium	-
2023-06-30	Premium	bought	Premium	Premium	Premium	-
2023-06-27	Premium	bought	Premium	Premium	Premium	-
2023-06-27	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	-
2023-03-16	Premium	acquired	Premium	Premium	Premium	-
2023-03-16	Premium	acquired	Premium	Premium	Premium	-
2023-03-16	Premium	acquired	Premium	Premium	Premium	-
2023-02-13	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2022-12-22	Premium	bought	Premium	Premium	Premium	SEE REMARKS
2022-12-21	Premium	bought	Premium	Premium	Premium	SEE REMARKS
2022-12-16	Premium	acquired	Premium	Premium	Premium	-
2022-12-16	Premium	acquired	Premium	Premium	Premium	-
2022-12-16	Premium	acquired	Premium	Premium	Premium	-

BDTX - Black Diamond Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for BDTX